Amoéba is a greentech company whose ambition is to become a major player in the treatment of microbiological risk based on the patented use of amoebae in the plant protection and cosmetics sectors. With know-how that is unique in the world and protected by numerous patents, Amoéba is currently the only company capable of exploiting the full potential of the Willaertia amoeba on an industrial scale and cultivating it in sufficient volumes to offer biological solutions that constitute a viable alternative to the chemical products widely used today. Amoéba is currently focusing on the global biocontrol market for plant protection and on the cosmetics market.

Employees

Sector

Agricultural Chemicals

More about the company

Market Cap	21.77M 24.5M 20.32M 18.52M 34.92M 2.36B 35.25M 246M 95.27M 1.2B 91.98M 89.99M 3.86B	P/E 2026 *	-4.21x	P/E 2027 *	31.6x
Enterprise Value	32.92M 37.05M 30.72M 28M 52.81M 3.56B 53.31M 372M 144M 1.82B 139M 136M 5.84B	EV / Sales 2026 *	6.45x	EV / Sales 2027 *	2.16x
Free-Float	87.09%	Yield 2026 *	-	Yield 2027 *	-

09-24	Amoéba S.A. Reports Earnings Results for the Half Year Ended June 30, 2026	CI
09-09	Amoéba, Syngenta Sign European Distribution Deal for Biocontrol Fungicide	MT
07-23	Amoéba and Koppert Extends Distribution Agreement for Axpera Technology and Reaffirm Their Shared Ambitions in the Field of Innovative Biofungicides	CI
07-01	Amoéba Receives Marketing Authorization For Biofungicide AXPERA In France	CI
06-30	Amoéba gains from marketing authorization in France
06-30	Amoéba Bags Marketing Approval for Biofungicide in France	MT
06-30	Amoéba wins marketing authorization in France
06-08	Amoéba S.A. Obtains 120-Day Emergency Authorization for Use of Biofungicide AXPERA Against Basil Downy Mildew in Italy	CI
06-08	Amoéba secures strategic emergency authorization in Italy
05-07	Amoéba Announces Two New Exceptional Trial Permits for Biocontrol Solution in the Netherlands	CI
04-28	Amoéba Announces Emergency Authorization for Axpera Biocontrol Solution	CI
04-28	Amoéba secures emergency authorization for downy mildew treatment in France
04-13	Amoéba and Koppert Highlight the Potential of Axpera Technology in Brazil for Strategic Crops	CI

10-02	Amoéba : Amoéba aims to involve its shareholders in its latest fundraising round, ahead of the monetisation of its cosmetics platform, to finance its commercial launch	AT
09-25	Amoéba : Amoéba announces the success of the first phase of its fundraising campaign aimed at achieving financial self-sufficiency	AT
09-24	Amoéba : Amoéba launches a two-phase capital increase expected to be its final market financing before achieving financial self-sufficiency	AT
09-24	Amoéba : Amoéba becomes an industrial and commercial company in biocontrol and initiates a process to monetize its cosmetics asset	AT
09-10	Syngenta and Amoéba Seal Exclusive European Distribution Deal, Aiming to Bring a Breakthrough Biofungicide to Cereal Growers	GL

10-02	Amoéba : Amoéba organise un webinaire le 7 octobre 2026 à 18h00 pour présenter son augmentation de capital ouverte à tous
10-02	Amoéba : Amoéba veut associer ses actionnaires à sa dernière levée de fonds, avant la monétisation de sa plateforme cosmétique, pour financer son démarrage commercial
09-25	Bourse : les Arnault à la Maison Blanche, HelloFresh avertit et Meta 2000
09-25	Amoéba : Amoéba annonce le succès de la première partie de sa levée de fonds destinée à atteindre l’autonomie financière
09-25	Le Nasdaq tient tête à l'obligataire

Manager	Title	Age	Since
Dominique Jean Francois Marie Doucet CEO	Chief Executive Officer	60	14/12/2023
Sandrine Troussieux CTO	Chief Tech/Sci/R&D Officer	-	01/09/2018
Jean-Baptiste Eberst LAW	General Counsel	-	01/07/2015

Amoéba Stock Euronext Paris

Stocks

Agricultural Chemicals

Valuation: Amoéba

Latest news: Amoéba

Press Releases: Amoéba

News in other languages: Amoéba

Managers and Directors: Amoéba

Pesticide

Financials

Company Profile

Director	Title	Age	Since
Valérie Filiatre BRD	Director/Board Member	-	01/06/2014
Benoît Villers CHM	Chairman	70	14/12/2023
Jean-luc Souche BRD	Director/Board Member	70	25/05/2023

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
AMOÉBA	-.--%	-11.21%	-	-	24.5M
CORTEVA, INC.	-5.17%	-71.47%	-	-	44.88B
NUTRIEN LTD.	+0.71%	-2.17%	+20.75%	+27.51%	33.47B
QINGHAI SALT LAKE INDUSTRY CO.,LTD	+1.40%	+0.55%	+14.29%	+38.87%	18.81B
CF INDUSTRIES HOLDINGS, INC.	+0.41%	+0.30%	+27.66%	+39.76%	17.41B
SABIC AGRI-NUTRIENTS COMPANY	-0.60%	-5.66%	0.00%	-13.24%	14.78B
PHOSAGRO	+0.11%	-.--%	-.--%	-.--%	12.96B
JORDAN PHOSPHATE MINES CO. PLC	+0.12%	+0.12%	+28.41%	+188.94%	11.31B
YARA INTERNATIONAL ASA	+0.24%	-4.11%	+12.88%	+5.17%	10.99B
ACRON	-0.22%	-.--%	-.--%	-.--%	8.3B
Average	-0.30%	-9.29%	+13.00%	+35.88%	19.21B
Weighted average by Cap.	-1.04%	-19.80%	+14.90%	+33.91%

	2026 *	2027 *
Net sales	5.1M 5.74M 4.76M 4.34M 8.18M 552M 8.26M 57.6M 22.32M 282M 21.55M 21.08M 905M	15.55M 17.5M 14.51M 13.23M 24.95M 1.68B 25.18M 176M 68.06M 860M 65.71M 64.28M 2.76B
Net income	-5.2M -5.85M -4.85M -4.42M -8.34M -563M -8.42M -58.73M -22.76M -288M -21.97M -21.5M -923M	550K 619K 513K 468K 882K 59.51M 891K 6.21M 2.41M 30.42M 2.32M 2.27M 97.63M
Net Debt	11.15M 12.55M 10.41M 9.49M 17.89M 1.21B 18.06M 126M 48.8M 617M 47.12M 46.09M 1.98B	11.85M 13.34M 11.06M 10.08M 19.01M 1.28B 19.19M 134M 51.87M 655M 50.07M 48.99M 2.1B